Retatrutide Study Evaluates Efficacy in Obese Type 2 Diabetes Patients | Retatrutide News

A study on retatrutide for type 2 diabetes patients with obesity is completed. It focused on efficacy and safety over 89 weeks.
Clinical Trials · October 16, 2026